About Processa Pharmaceuticals (OTCMKTS:PCSA)
Processa Pharmaceuticals, Inc., formerly Heatwurx, Inc., is a pharmaceutical company. The Company is focused on the development of drug products that are intended to improve the survival and/or quality of life for patients who have unmet medical need. The Company’s product portfolio includes 499. It is developing 499 for the treatment of Necrobiosis Lipoidica. It is also developing 499 for the treatment of effects related to head and neck cancer.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Book Value($0.21) per share
Price / Book-16.00
Return on EquityN/A
Return on Assets-1,994.61%
Processa Pharmaceuticals (OTCMKTS:PCSA) Frequently Asked Questions
What is Processa Pharmaceuticals' stock symbol?
Processa Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PCSA."
When will Processa Pharmaceuticals make its next earnings announcement?
Who are some of Processa Pharmaceuticals' key competitors?
Some companies that are related to Processa Pharmaceuticals include Kaman (KAMN), ESCO Technologies (ESE), Actuant (ATU), Multi-Color (LABL), Sun Hydraulics (SNHY), Mobile Mini (MINI), MRC Global (MRC), General Cable (BGC), Harsco (HSC), Chart Industries (GTLS), Altra Industrial Motion (AIMC), Apogee Enterprises (APOG), Hyster-Yale Materials Handling (HY), Hollysys Automation Technologies (HOLI), ACCO Brands (ACCO), Atkore International Group (ATKR), H&E Equipment Services (HEES) and Alamo Group (ALG).
Who are Processa Pharmaceuticals' key executives?
Processa Pharmaceuticals' management team includes the folowing people:
- David Young Ph.D., Chairman of the Board, Chief Executive Officer, Interim Chief Financial Officer, Founder
- Wendy Guy, Founder, Chief Administrative Officer
- Patrick Lin, Founder, Chief Business & Strategy Officer, Internal Director
- Sian Bigora, Chief Development Officer, Founder
- Virgil D. Thompson, Director
- Justin W. Yorke, Director
How do I buy Processa Pharmaceuticals stock?
Shares of Processa Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Processa Pharmaceuticals' stock price today?
One share of Processa Pharmaceuticals stock can currently be purchased for approximately $3.36.
How big of a company is Processa Pharmaceuticals?
Processa Pharmaceuticals has a market capitalization of $829.61 million. The company earns $-330,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis. Processa Pharmaceuticals employs 1 workers across the globe.
How can I contact Processa Pharmaceuticals?
Processa Pharmaceuticals' mailing address is 7380 Coca Cola Dr Ste 106, HANOVER, MD 21076-1789, United States. The company can be reached via phone at +1-443-7763133.
MarketBeat Community Rating for Processa Pharmaceuticals (PCSA)MarketBeat's community ratings are surveys of what our community members think about Processa Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Processa Pharmaceuticals (OTCMKTS:PCSA) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Earnings History for Processa Pharmaceuticals (OTCMKTS:PCSA)
No earnings announcements for this company have been tracked by MarketBeat.com
Processa Pharmaceuticals (OTCMKTS:PCSA) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Processa Pharmaceuticals (OTCMKTS:PCSA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Processa Pharmaceuticals (OTCMKTS PCSA)
No insider trades for this company have been tracked by MarketBeat.com
Processa Pharmaceuticals (OTCMKTS PCSA) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Processa Pharmaceuticals (OTCMKTS:PCSA) SEC Filings
Financials are not available for this stock.
Processa Pharmaceuticals (OTCMKTS PCSA) Stock Chart for Monday, December, 11, 2017